\n\n\n\n\t\t\n\t\t\tZARS Pharma\n\t\t\thttp://www.zars.com/\n\t\t
\n\t\t\n\t\t\tWatch Company\n\t\t\tGet Widget\n\t\t
\n\tZARS Pharma is a specialty pharmaceutical company focused on the development and commercialization of topically administered drugs using proprietary drug delivery technologies, primarily in the area...More»
\n\t\t\tZARS Pharma is a specialty pharmaceutical company focused on the development and commercialization of topically administered drugs using proprietary drug delivery technologies, primarily in the area of pain management and dermatology. ZARS Pharma has developed a portfolio of proprietary products and product candidates based on the CHADD(R) technology and on cream technologies (Peel and DuraPeel(TM)) that transform, or phase- change, from an initial liquid phase to a solid phase during application. The product portfolio for ZARS Pharma includes two products that have been approved for marketing (Pliaglis and Synera(R), the latter marketed as Rapydan(R) in Europe). ZARS Pharma currently has one product in a late-stage clinical trial that commenced in June 2007 (ThermoProfen(TM)) and four additional products that have entered various stages of clinical development.«Less
\n\n\t\t\tOverview
\n\t\t\t\tLocation: \tSalt Lake City, UT, United States\n
\n\t\t\t\tIndustry: Biopharmaceuticals
\n\t\t\t\tTags:\n\t\t\t\tdrugs,\n\t\t\t\tpharmaceuticals,\n\t\t\t\tdrug delivery\n\t\t\t\t
\n\t\t\tMarket
\n\n\t\t\t\tRelated Companies:\n\t\t\t\t\tACT Biotech,\n\t\t\t\t\tPearl Therapeutics,\n\t\t\t\t\tPharma Engine,\n\t\t\t\t\tDirect Therapeutics,\n\t\t\t\t\tOptimer Pharmaceuticals,\n\t\t\t\t\tMedipacs,\n\t\t\t\t\tCogentus Pharmaceuticals,\n\t\t\t\t\tAcelRx Pharmaceuticals,\n\t\t\t\t\tQuestcor Pharmaceuticals,\n\t\t\t\t\tNuvelo\n\t\t\t\t
\n\t\t\t